Skip to main content

Expedition Therapeutics

San Francisco, United States

Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.

$165.0M raised
Oct 2025
Series A

Top Investors

VenrockForbion Capital PartnersNovo HoldingsSofinnova InvestmentsSanofi Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Expedition Therapeutics

How much funding has Expedition Therapeutics raised?
Expedition Therapeutics has raised $165.0M in total funding. The most recent round was Series A. The last funding was announced in October 2025.
Who are Expedition Therapeutics's investors?
Expedition Therapeutics's investors include Venrock, Forbion Capital Partners, Novo Holdings, Sofinnova Investments, Sanofi Ventures.
Where is Expedition Therapeutics headquartered?
Expedition Therapeutics is headquartered in San Francisco, United States.
What does Expedition Therapeutics do?
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.
What stage is Expedition Therapeutics at?
Expedition Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Expedition Therapeutics — Funding & Investors." VCBacked, October 9, 2025, https://www.vcbacked.co/company/expedition-therapeutics. Accessed June 7, 2026.
APA
VCBacked. (2025). Expedition Therapeutics — Funding & Investors. Retrieved June 7, 2026, from https://www.vcbacked.co/company/expedition-therapeutics
Wikipedia (cite web)
{{cite web |title=Expedition Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/expedition-therapeutics |website=VCBacked |access-date=June 7, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .